Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccine

References

• Neuzil KM, Coffey CS, Mitchel EF, Jr., Griffin MR. Cardiopulmonary hospitalizations during influenza season in adults and adolescents with advanced HIV infection. J Acquir Immune Defic Syndr 2003; 34:304-7; PMID:14600576; http://dx.doi.org/10.1097/00126334-200311010-00008
   PubMed Web of Science ®Google Scholar
• Lin JC, Nichol KL. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med 2001; 161:441-6; PMID:11176770; http://dx.doi.org/10.1001/archinte.161.3.441
   PubMed Web of Science ®Google Scholar
• Pinto LA, Blazevic V, Anderson SA, Venzon DJ, Trubey CM, Rowe T, Katz JM, Liewehr D, Dolan MJ, Shearer GM. Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects. J Infect Dis 2001; 183:1000-8; PMID:11237823; http://dx.doi.org/10.1086/319277
   PubMed Web of Science ®Google Scholar
• Santini-Oliveira M, Camacho LA, Souza TM, Luz PM, Vasconcellos MT, Giacoia-Gripp CB, Morgado MG, Nunes EP, Lemos AS, Ferreira AC, et al. H1N1pdm09 adjuvanted vaccination in HIV-infected adults: a randomized trial of two single versus two double doses. PloS one 2012; 7:e39310; PMID:22761759; http://dx.doi.org/10.1371/journal.pone.0039310.
   PubMedGoogle Scholar
• Crum-Cianflone NF, Eberly LE, Duplessis C, Maguire J, Ganesan A, Faix D, Defang G, Bai Y, Iverson E, Lalani T, et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults. Clin Infect Dis 2011; 52:138-46; PMID:21148532; http://dx.doi.org/10.1093/cid/ciq019.
   PubMed Web of Science ®Google Scholar
• Miotti PG, Nelson KE, Dallabetta GA, Farzadegan H, Margolick J, Clements ML. The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA 1989; 262:779-83; http://dx.doi.org/10.1001/jama.1989.03430060075029.
   PubMed Web of Science ®Google Scholar
• Nelson KE, Clements ML, Miotti P, Cohn S, Polk BF. The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. Ann Intern Med 1988; 109:383-8; PMID:2970238; http://dx.doi.org/10.7326/0003-4819-109-5-383.
   PubMed Web of Science ®Google Scholar
• Malaspina A, Moir S, Orsega SM, Vasquez J, Miller NJ, Donoghue ET, Kottilil S, Gezmu M, Follmann D, Vodeiko GM, et al. Compromised B cell responses to influenza vaccination in HIV-infected individuals. J Infect Dis 2005; 191:1442-50; PMID:15809902; http://dx.doi.org/10.1086/429298.
   PubMed Web of Science ®Google Scholar
• Klein MB, Lu Y, DelBalso L, Cote S, Boivin G. Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination. Clin Infect Dis 2007; 45:234-40; PMID:17578785; http://dx.doi.org/10.1086/518986.
   PubMed Web of Science ®Google Scholar
• Young F, Marra F. A systematic review of intradermal influenza vaccines. Vaccine 2011; 29:8788-801; PMID:21968444; http://dx.doi.org/10.1016/j.vaccine.2011.09.077.
   PubMed Web of Science ®Google Scholar
• Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004; 351:2295-301; PMID:15525714; http://dx.doi.org/10.1056/NEJMoa043540.
   PubMed Web of Science ®Google Scholar
• Durando P, Fenoglio D, Boschini A, Ansaldi F, Icardi G, Sticchi L, Renzoni A, Fabbri P, Ferrera A, Parodi A, et al. Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults. Clin Vaccine Immunol 2008; 15:253-9; PMID:18003811; http://dx.doi.org/10.1128/CVI.00316-07.
   PubMed Web of Science ®Google Scholar
• Gabutti G, Guido M, Durando P, De Donno A, Quattrocchi M, Bacilieri S, Ansaldi F, Cataldini S, Chiriac∫ PG, De Simone M, et al. Safety and immunogenicity of conventional subunit and MF59-adjuvanted influenza vaccines in human immunodeficiency virus-1-seropositive patients. J Int Med Res 2005; 33:406-16; PMID:16104444; http://dx.doi.org/10.1177/147323000503300406.
   PubMed Web of Science ®Google Scholar
• McKittrick N, Frank I, Jacobson JM, White CJ, Kim D, Kappes R, DiGiorgio C, Kenney T, Boyer J, Tebas P. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial. Ann Intern Med 2013; 158:19-26; PMID:23277897; http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00005.
   PubMed Web of Science ®Google Scholar
• Cooper C, Thorne A, Klein M, Conway B, Boivin G, Haase D, Shafran S, Zubyk W, Singer J, Halperin S, et al. Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults. PloS One 2011; 6:e17758; PMID:21512577; http://dx.doi.org/10.1371/journal.pone.0017758.
   PubMed Web of Science ®Google Scholar
• Palucka K, Banchereau J, Mellman I. Designing vaccines based on biology of human dendritic cell subsets. Immunity 2010; 33:464-78; PMID:21029958; http://dx.doi.org/10.1016/j.immuni.2010.10.007.
   PubMed Web of Science ®Google Scholar
• Ansaldi F, Valle L, de Florentiis D, Parodi V, Murdaca G, Bruzzone B, Durando P, Setti M, Icardi G. Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. Hum Vaccin Immunother 2012; 8:1048-52; PMID:22832261; http://dx.doi.org/10.4161/hv.20347.
   PubMed Web of Science ®Google Scholar
• Troy SB, Kouiavskaia D, Siik J, Kochba E, Beydoun H, Mirochnitchenko O, Levin Y, Khardori N, Chumakov K, Maldonado Y. Comparison of the immunogenicity of various booster doses of inactivated polio vaccine delivered intradermally versus intramuscularly to HIV-infected adults. J Infect Dis 2015; 211:1969-76; PMID:25567841; http://dx.doi.org/10.1093/infdis/jiu841.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Maskew M, Koen A, Kuwanda L, Besselaar TG, Naidoo D, Cohen C, Valette M, Cutland CL, Sanne I. Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety. Clin Infect Dis 2011; 52:128-37; PMID:21148531; http://dx.doi.org/10.1093/cid/ciq004.
   PubMed Web of Science ®Google Scholar
• Schneider MM, Sprenger MJ, Hoepelman IM, van der Graaf Y, Borleffs JC. Antibody response to tetravalent influenza subunit vaccine in patients infected with human immunodeficiency virus type 1. Int J Antimicrob Agents 1996; 6:195-200; PMID:18611709; http://dx.doi.org/10.1016/0924-8579(95)00038-0.
   PubMed Web of Science ®Google Scholar
• Kroon FP, van Dissel JT, de Jong JC, van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. Aids 1994; 8:469-76; PMID:7912086; http://dx.doi.org/10.1097/00002030-199404000-00008.
   PubMed Web of Science ®Google Scholar
• Cooper CL. Pandemic H1N12009 influenza and HIV: a review of natural history, management and vaccine immunogenicity. Curr Opin Infect Dis 2012; 25:26-35; PMID:22183114; http://dx.doi.org/10.1097/QCO.0b013e32834ef56c.
   PubMed Web of Science ®Google Scholar
• Kroon FP, van Dissel JT, de Jong JC, Zwinderman K, van Furth R. Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. Vaccine 2000; 18:3040-9; PMID:10825608; http://dx.doi.org/10.1016/S0264-410X(00)00079-7.
   PubMed Web of Science ®Google Scholar
• Kishida N, Fujisaki S, Yokoyama M, Sato H, Saito R, Ikematsu H, Xu H, Takashita E, Tashiro M, Takao S, et al. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs. Clin Vaccine Immunol 2012; 19:897-908; PMID:22492743; http://dx.doi.org/10.1128/CVI.05726-11.
   PubMed Web of Science ®Google Scholar
• Cheong HJ, Song JY, Park JW, Yeon JE, Byun KS, Lee CH, Cho HI, Kim TG, Kim WJ. Humoral and cellular immune responses to influenza vaccine in patients with advanced cirrhosis. Vaccine 2006; 24:2417-22; PMID:16406176; http://dx.doi.org/10.1016/j.vaccine.2005.11.064.
   PubMed Web of Science ®Google Scholar